PCD Versus RCD for the Treatment of Patients With Waldenstrom's Macroglobulinemia

NCT02971982 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Treatment

Interventions

DRUG: rituximab /Dexamethasone/cyclophosphamide
DRUG: Velcade/Dexamethasone/cyclophosphamide

Sponsor

The First Affiliated Hospital of Soochow University